2291 Stock Overview
An investment holding company, engages in the research, development, manufacture, and commercialization of interventional medical devices worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 1/6 |
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$16.10 |
| 52 Week High | HK$31.55 |
| 52 Week Low | HK$13.00 |
| Beta | 0 |
| 11 Month Change | -5.18% |
| 3 Month Change | -16.06% |
| 1 Year Change | -46.15% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -46.78% |
Recent News & Updates
Recent updates
Shareholder Returns
| 2291 | HK Medical Equipment | HK Market | |
|---|---|---|---|
| 7D | 15.3% | 6.7% | 9.8% |
| 1Y | -46.2% | -37.0% | 12.9% |
Return vs Industry: 2291 underperformed the Hong Kong Medical Equipment industry which returned -37% over the past year.
Return vs Market: 2291 underperformed the Hong Kong Market which returned 12.9% over the past year.
Price Volatility
| 2291 volatility | |
|---|---|
| 2291 Average Weekly Movement | 8.2% |
| Medical Equipment Industry Average Movement | 7.5% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in HK Market | 13.6% |
| 10% least volatile stocks in HK Market | 3.5% |
Stable Share Price: 2291's share price has been volatile over the past 3 months.
Volatility Over Time: 2291's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | 219 | Juan Chen | www.scientechmed.com |
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd., an investment holding company, engages in the research, development, manufacture, and commercialization of interventional medical devices worldwide. The company offers congenital heart diseases interventional treatment solutions, including atrial septal defect, ventricular septal defect, and patent ductus arteriosus occluder products; delivery systems; and snare products. It also provides cardioembolic stroke prevention solutions, such as left atrial appendage and patent foramen ovale occluder products; treatment of valvular disease solutions comprising aortic valve products, mitral valve products, tricuspid valve products, pulmonary valve products, and procedural accessories; and vascular plugs and interatrial shunt devices.
LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Fundamentals Summary
| 2291 fundamental statistics | |
|---|---|
| Market cap | HK$5.58b |
| Earnings (TTM) | HK$168.01m |
| Revenue (TTM) | HK$361.34m |
33.2x
P/E Ratio15.4x
P/S RatioIs 2291 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2291 income statement (TTM) | |
|---|---|
| Revenue | CN¥325.90m |
| Cost of Revenue | CN¥37.09m |
| Gross Profit | CN¥288.81m |
| Other Expenses | CN¥137.28m |
| Earnings | CN¥151.53m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.44 |
| Gross Margin | 88.62% |
| Net Profit Margin | 46.50% |
| Debt/Equity Ratio | 0% |
How did 2291 perform over the long term?
See historical performance and comparison